Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Healthwell Acquisition Corp. I Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/02/2023 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
08/18/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/11/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/11/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Second Amendment to Business Combination Agreement, by and among Healthwell Acquisition Corp. I, Healthwell Acquisition Corp. I Sponsor LLC, HWEL Holdings Corp., HWEL Merger Sub Corp., 1412384 B.C. Unlimited Liability Company, 1412388 B.C. Ltd, Starton Therapeutics, Inc. and Kiriakos Charlie Perperidis"
08/01/2023 8-K Quarterly results
07/31/2023 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/25/2023 8-K Quarterly results
07/25/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/25/2023 8-K Quarterly results
07/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/21/2023 8-K Quarterly results
07/10/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/10/2023 8-K Quarterly results
07/03/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/29/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
06/13/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Presentation"
06/12/2023 425 Form 425 - Prospectuses and communications, business combinations:
06/12/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma · FDA agrees to the planned Phase 1b study in second-line transplant ineligible patients in multiple myeloma · Treatment regimen will include Velcade® and dexamethasone and replace oral Revlimid® with STAR-LLD PARAMUS, N.J., June 12, 2023 – Starton Therapeutics Inc. , a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma. The U.S. Food and Drug Administration notified the Company that it may proceed with the U.S.-based ..."
06/07/2023 SC 13G CANTOR FITZGERALD SECURITIES reports a 5.1% stake in Healthwell Acquisition Corp. I
05/18/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/15/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "FIRST AMENDMENT TO BUSINESS COMBINATION AGREEMENT"
05/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/03/2023 8-K Quarterly results
04/27/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/27/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/27/2023 8-K Quarterly results
03/23/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note",
"Promissory Note"
02/14/2023 SC 13G/A Apollo Management Holdings GP, LLC reports a 9.3% stake in Healthwell Acquisition Corp. I
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy